The non-steroidal mineralocorticoid receptor antagonist finerenone improves left ventricular function in preclinical chronic kidney disease
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Aldosterone Antagonists
Session:
Pharmacology and pharmacotherapy e-posters